<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Sawka AM</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>In managing early-stage cancers, active surveillance (AS) may be preferentially favored by older individuals. In counseling patients, it is important to understand the durability of AS in the context of age.&lt;h4>Objective&lt;/h4>To evaluate the durability of AS in patients with small, low-risk papillary thyroid cancer (PTC) according to age at the time of choosing AS.&lt;h4>Design, setting, and participants&lt;/h4>This single-center, prospective, long-term follow-up cohort study was conducted at a tertiary care hospital in Toronto, Ontario, Canada. Adult patients with small, localized, low-risk PTC less than 2 cm in maximal diameter were enrolled between May 2016 and February 2021. The clinical outcome data were analyzed up to the time point of May 25, 2025, and final data analysi</pubmed_abstract><journal>JAMA surgery</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12368792</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Long-Term Durability of Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer.</pubmed_title><pmcid>PMC12368792</pmcid><pubmed_authors>Shah M</pubmed_authors><pubmed_authors>Higgins K</pubmed_authors><pubmed_authors>Hay M</pubmed_authors><pubmed_authors>Gooden E</pubmed_authors><pubmed_authors>Su J</pubmed_authors><pubmed_authors>Devon K</pubmed_authors><pubmed_authors>Solomon P</pubmed_authors><pubmed_authors>Witterick I</pubmed_authors><pubmed_authors>Jones JM</pubmed_authors><pubmed_authors>Gantous A</pubmed_authors><pubmed_authors>Halperin IJ</pubmed_authors><pubmed_authors>Gilbert R</pubmed_authors><pubmed_authors>Esemezie AO</pubmed_authors><pubmed_authors>Bindlish V</pubmed_authors><pubmed_authors>Eskander A</pubmed_authors><pubmed_authors>Pasternak JD</pubmed_authors><pubmed_authors>Whiteacre L</pubmed_authors><pubmed_authors>Anand S</pubmed_authors><pubmed_authors>de Almeida J</pubmed_authors><pubmed_authors>Goldstein DP</pubmed_authors><pubmed_authors>Lin D</pubmed_authors><pubmed_authors>Vescan A</pubmed_authors><pubmed_authors>Enepekides D</pubmed_authors><pubmed_authors>Tsang RW</pubmed_authors><pubmed_authors>Xu W</pubmed_authors><pubmed_authors>Nazarali K</pubmed_authors><pubmed_authors>Baxter NN</pubmed_authors><pubmed_authors>Rotstein L</pubmed_authors><pubmed_authors>Canadian Thyroid Cancer Active Surveillance Study Group (Greater Toronto Area)</pubmed_authors><pubmed_authors>Bharadwaj V</pubmed_authors><pubmed_authors>Irish JC</pubmed_authors><pubmed_authors>Ezzat S</pubmed_authors><pubmed_authors>Banerjee A</pubmed_authors><pubmed_authors>Prudencio J</pubmed_authors><pubmed_authors>Sawka AM</pubmed_authors><pubmed_authors>Ghai S</pubmed_authors><pubmed_authors>Gullane PJ</pubmed_authors><pubmed_authors>Hafidh M</pubmed_authors><pubmed_authors>Segall L</pubmed_authors><pubmed_authors>Korman M</pubmed_authors><pubmed_authors>Fernandes V</pubmed_authors><pubmed_authors>Chang M</pubmed_authors><pubmed_authors>Monteiro E</pubmed_authors><pubmed_authors>Madani A</pubmed_authors><pubmed_authors>Arruda E</pubmed_authors><pubmed_authors>Chung J</pubmed_authors><pubmed_authors>Gevorgyan A</pubmed_authors><pubmed_authors>Gomez Hernandez K</pubmed_authors><pubmed_authors>Anderson J</pubmed_authors><pubmed_authors>Zahedi A</pubmed_authors><pubmed_authors>Gafni A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-Term Durability of Active Surveillance of Small, Low-Risk Papillary Thyroid Cancer.</name><description>&lt;h4>Importance&lt;/h4>In managing early-stage cancers, active surveillance (AS) may be preferentially favored by older individuals. In counseling patients, it is important to understand the durability of AS in the context of age.&lt;h4>Objective&lt;/h4>To evaluate the durability of AS in patients with small, low-risk papillary thyroid cancer (PTC) according to age at the time of choosing AS.&lt;h4>Design, setting, and participants&lt;/h4>This single-center, prospective, long-term follow-up cohort study was conducted at a tertiary care hospital in Toronto, Ontario, Canada. Adult patients with small, localized, low-risk PTC less than 2 cm in maximal diameter were enrolled between May 2016 and February 2021. The clinical outcome data were analyzed up to the time point of May 25, 2025, and final data analysi</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-29T15:24:56.659Z</modification><creation>2026-04-08T05:18:43.107Z</creation></dates><accession>S-EPMC12368792</accession><cross_references><pubmed>40833769</pubmed><doi>10.1001/jamasurg.2025.2957</doi></cross_references></HashMap>